[HTML][HTML] The impact of early molecular response in event free survival in patients with chronic myeloid leukemia treated with imatinib
L Fogliatto, MEZ Capra, M Shaan, TV Costa… - Blood, 2014 - Elsevier
Background Monitoring response to TKI therapy is one of the key management strategies of
chronic myeloid leukemia (CML). Early molecular response to first-line TKI therapy is …
chronic myeloid leukemia (CML). Early molecular response to first-line TKI therapy is …
The Impact of Early Molecular Response in Event Free Survival in Patients with Chronic Myeloid Leukemia Treated with Imatinib
L Fogliatto, MEZ Capra, M Shaan, TV Costa… - 2014 - ashpublications.org
Background Monitoring response to TKI therapy is one of the key management strategies of
chronic myeloid leukemia (CML). Early molecular response to first-line TKI therapy is …
chronic myeloid leukemia (CML). Early molecular response to first-line TKI therapy is …